Garenoxacin
|
|
|
- CAS-Nr.
- 223652-90-2
- Englisch Name:
- Garenoxacin
- Synonyma:
- Garenoxacin mesylate [USAN];BMS284756 (Mesylate hydrate);Garenoxacin mesylate hydrate;Garenoxacin mesylate monohydrate;Garenoxacin mesylate monohydrate >=98% (HPLC);1-cyclopropyl-8-(difluoromethoxy)-4-keto-7-[(1R)-1-methylisoindolin-5-yl]quinoline-3-carboxylic acid;1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylicacid,methanesulfonicacid,hydrate;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate;(R)-1-cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound with methanesulfonic acid (1:1) hydrate;Garenoxacin mesylate hydrate
1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate
- CBNumber:
- CB8947028
- Summenformel:
- C23H20F2N2O4.CH4O3S.H2O
- Molgewicht:
- 540.53
- MOL-Datei:
- 223652-90-2.mol
|
Garenoxacin Eigenschaften
- storage temp.
- 2-8°C
- Löslichkeit
- DMSO:100.0(Max Conc. mg/mL);185.0(Max Conc. mM)
Water:12.5(Max Conc. mg/mL);23.13(Max Conc. mM)
- Aggregatzustand
- powder
- Farbe
- white to beige
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
Garenoxacin Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Antibacterial agent.
Garenoxacin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Garenoxacin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 64)Lieferanten
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate
- Garenoxacin mesylate hydrate
- Garenoxacin mesylate hydrate
1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate
- (R)-1-cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound with methanesulfonic acid (1:1) hydrate
- 1-cyclopropyl-8-(difluoromethoxy)-4-keto-7-[(1R)-1-methylisoindolin-5-yl]quinoline-3-carboxylic acid
- BMS284756 (Mesylate hydrate)
- Garenoxacin mesylate [USAN]
- Garenoxacin mesylate monohydrate >=98% (HPLC)
- 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylicacid,methanesulfonicacid,hydrate
- Garenoxacin mesylate hydrate,DNA/RNA Synthesis,Topoisomerase,S. pneumonia,S. aureus,gyrase,Garenoxacin Mesylate,ureaplasmas,Inhibitor,BMS284756 Mesylate,topoisomerase IV,Swiss mice,inhibit,Bacterial,mycoplasmas,Antibiotic
- Garenoxacin mesylate monohydrate
- 223652-90-2
- C23H20F2N2O4CH4O3SH2O
- C24H26F2N2O8S
